The Drug Discovery Outsourcing Market is estimated to be valued at US$ 3,825.2 Mn in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Drug discovery outsourcing refers to the process of contracting out portions of the drug development process to outside partners or vendors. This allows pharmaceutical companies to reduce their internal costs and access specialized expertise and infrastructure that may not be available in-house. Outsourcing renders R&D more flexible and improves productivity by focusing internal resources on core competencies.
Market key trends:
One of the major trends driving growth in the Global Drug Discovery Outsourcing Market Size is the significant rise in R&D investments by pharmaceutical companies. According to a report by Pharmaceutical Research and Manufacturers of America (PhRMA), R&D spending by U.S. biopharmaceutical companies increased to US$ 83 billion in 2021 from US$ 79.6 billion in 2020. As drug discovery remains a highly complex and capital-intensive process, outsourcing allows companies to access advanced technologies and specialized capabilities at lower costs. This helps optimize research budgets and enhance success rates in new drug development.
Porter's Analysis
Threat of new entrants: Drug discovery is a capital intensive process and the regulatory hurdles are high, making entry difficult for new players. However, outsourcing allows startups to leverage capabilities of big CROs.
Bargaining power of buyers: Large pharmaceutical companies have significant bargaining power due to the fragmented nature of suppliers and their ability to drive competition. However, dependence on outsourcing keeps seller power in balance.
Bargaining power of suppliers: Several supplier capabilities overlap, increasing competition, but complex service needs keep power in balance. Switching costs are relatively low as quality providers abound.
Threat of new substitutes: Few technologies can currently substitute for outsourcing’s value in reducing risks and costs of drug discovery programs. However, open innovation models pose a threat to scale.
Competitive rivalry: Intense as the global market is highly fragmented with low switching costs and balanced power dynamics between buyers and numerous mid-sized suppliers. M&A activity is high to gain scale and capabilities.
SWOT Analysis
Strengths: Access to advanced infrastructure, expertise across all phases of discovery.
Weaknesses: Dependency on client pipelines exposes business cycles, regulatory changes impact operations.
Opportunities: Emerging modalities like gene and cell therapies require heavy R&D investments, driving need for outsourcing.
Threats: Data security and IP concerns for sensitive research, political risks from geo-economic uncertainties.
Key Takeaways
The global drug discovery outsourcing market is expected to witness high growth, exhibiting a CAGR of 6.4% over the forecast period, due to increasing R&D costs and productivity pressures. North America currently dominates due to presence of most pharmaceutical companies and investors, however, Asia Pacific is emerging as a fast-growing regional market.
Regional analysis: The Asia Pacific drug discovery outsourcing market is projected to grow at the fastest pace over the next few years due to increasing investments from big pharmaceutical companies seeking to leverage lower costs and a growing skilled workforce. China and India are strategically important markets, especially for services related to computational modeling and medicinal chemistry.
Key players operating in the drug discovery outsourcing market include Curia, Genscript, Evotec, Eurofins Scientific, and Laboratory Corporation of America Holdings, among others. While large players aim to offer end-to-end services across all phases, mid-sized companies focus on specialized capabilities to sustain competition. Increasing M&A remains an important strategy for market consolidation as outsourcing needs grow more complex.
Read Our More Blogs : https://www.dailyprbulletin.com/drug-discovery-outsourcing-market-forecast-outlook-trend-2023-2030/
Sign in to leave a comment.